Bioremediation differs from other industrial biotechnologies in that, although bioremediation contractors must profit from the activity, the primary driver is regulatory compliance rather than manufacturing profit. It is an attractive technology in the context of a bioeconomy but currently has limitations at the field scale. Ecogenomics techniques may address some of these limitations, but a further challenge would be acceptance of these techniques by regulators.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tibtech.2013.01.015 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!